CG Oncology, Inc. Common stockCGONNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
79.45%
↑ 63% above average
Average (3y)
48.88%
Historical baseline
Range
High:79.45%
Low:0.00%
Volatility
162.5%
High variability
| Period | Value |
|---|---|
| 2024 | 79.45% |
| 2023 | 57.61% |
| 2022 | 58.46% |
| 2021 | 0.00% |